TARA OLDHAM: Open Payments
NPI 1871162743 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,534 in 90 payments from 24 companies in 2025. Trend: 2023 $937 · 2024 $1,262 · 2025 $1,534
Food & beverage: $1,534
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $411 |
| Novo Nordisk Inc | 19 | $281 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $190 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 3 | $46 |
| Kowa Pharmaceuticals America, Inc. | 3 | $45 |
| GlaxoSmithKline, LLC. | 3 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $38 |
Products named: CAPLYTA, QULIPTA, UBRELVY, Rybelsus, Wegovy, VRAYLAR, Ozempic, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
